Philip Schauer, MD retweeted
Wonderful to have @DrEricDeMaria present @YaleSurgery annual Margaret Oddsdottir Lecture! @Yale @YaleMed @ECUHealthNC
Philip Schauer, MD retweeted
Touchstone Diabetes Center group meeting 10/26/26 Link for full presentation
touchstonelabs.org/wp-conten…
Helen is the best! I knew she was destined to be an academic star when she was our Fellow at Cleveland Clinic many years ago! Way to go Helen!
Latest episode - Helen Heneghan talks obesity, the future of academic surgery and chicken... youtu.be/TAB3qP4n5Lw?si=QxJW… via @YouTube
#surgeonslives #stuffthatmatters
@juliomayol @jules_cornish @RCSI_Irl @NUIGMedicine @ucddublin @svuh @SoniaRamMD @PSchauerMD @NeilFlochMD
Philip Schauer, MD retweeted
Early obstruction after gastric bypass? A new systematic review describes 29 clot-related JJ obstructions, usually within 72 hours. Rare, but worth remembering when obstruction and bleeding coexist. Evidence is retrospective. link.springer.com/article/10…
Philip Schauer, MD retweeted
The latest Staple Line is out: surgery and cancer, late clots after sleeve, and Revita after tirzepatide. Catch the Oct. 21 episode of the MBS Digest audio edition: mbs-digest.com/podcast/s/the…
Philip Schauer, MD retweeted
In an 88,689-case TriNetX analysis, 29% of sleeve-associated portomesenteric thromboses were diagnosed after week 4; a 30-day window misses part of the burden. Anticoagulant data were unavailable. Disclosure: Dr. Schauer is a coauthor. MBS Digest Vol. 2, Issue 15. Link in reply.
Philip Schauer, MD retweeted
MBS Digest Vol. 2, Issue 15: bariatric surgery and cancer incidence in 784,105 Nordic adults (aIRR 0.81; pancreatic cancer 1.19); 29% of sleeve-associated portomesenteric thromboses diagnosed after week 4; 12-year RYGB mortality 4.34% vs 7.11%. Link in reply.
Philip Schauer, MD retweeted
A patient with obesity does not arrive as a surgical problem or a medication problem. MBS Digest is changing its name to match: it is now the Metabolic and Bariatric Sciences Digest. Same MBS, same weekly briefing, a wider view of the evidence.
Philip Schauer, MD retweeted
The Production Editor's editorial on why the name changed: mbs-digest.com/p/a-name-that…
Philip Schauer, MD retweeted
MBS Digest has a new full name: the Metabolic and Bariatric Sciences Digest. The initials, the weekly briefing and the editorial board stay the same. Surgery remains central; the name now covers the full range of obesity care our readers work in.
There’s still time to join us November 5-7 in Las Vegas for ASMBS Weekend 2026! Registration is open, and rooms are still available at Paris Las Vegas at the current hotel rate. Register today: asmbeweekend.com
We hope to see you there!
#ASMBSWeekend #ASMBS
Philip Schauer, MD retweeted
METABOLIC BARIATRIC SURGERY (MBS) achieves the best long-term results when it is part of a comprehensive, multidisciplinary care plan.
Coordinated care improves safety, outcomes, and quality of life for patients
Philip Schauer, MD retweeted
October is #BreastCancerAwareness Month
When women have a better self-image, they are more physically active which may reduce their risk of chronic health issues…including reducing their risk of breast #cancer recurrence. bit.ly/3KVfcPi
@Hologic #MediflixOriginal
Philip Schauer, MD retweeted
Weight recurrence deserves a careful revision discussion, not an automatic trip back to the OR. ASMBS is highlighting its Weekend session, ‘Just One More Hand: Weight Recurrence Revisions.’ Education, not a new outcomes study. xitter.cf/ASMBS/status/211040105…
Join us for “Just One More Hand: Weight Recurrence Revisions” at #ASMBSWeekend: buff.ly/5XPqLLp
#ASMBSWeekend #ASMBS #BariatricSurgery #MetabolicHealth #Health #MedEd #CME #CE #MedicalConference #HealthcareEducation #IntegratedHealth #surgery #SurgEd #BariatricNurse
Philip Schauer, MD retweeted
Great experience at #SPCO in beautiful Porto 🇵🇹!
Shared my vision, IFSO’s strategy, and the future of AI in obesity care.
Thanks to SPCO 🇵🇹 President John Preto and @aec_obesidad SECO 🇪🇸 President Fátima Sabench for their leadership and collaboration!
Porto will host #IFSO European Chapter 2029!
@IFSO_NAC @IFSOMENAC @IfsoSecretariat @ifso_ec @IFSOLAC
@JNJMedTech
@Medtronic
@IntuitiveSurg
@bostonsci
@EliLillyandCo
🤖 Made with AI
Philip Schauer, MD retweeted
Approximately 1 in 4 active-duty male U.S. Army personnel may have a morning testosterone measurement below a commonly used clinical threshold, according to new research from Pennington Biomedical Research Center published this week in JAMA. The findings provide estimates of low testosterone screening results across the active-duty Army population and offer insight into the potential implications of routine testosterone screening for military personnel. To view the full article, visit hubs.ly/Q04Bh-_h0
Philip Schauer, MD retweeted
Can AI and wearable tech help teens build healthier habits? 📱
A new Pennington Biomedical pilot study explored technology-assisted summer obesity prevention.
Read more: pbrc.edu/news/media/2026/fro…
@LSU @LSUCHSE @ololhealth @ololchildrens
But, prevalence of Extreme Obesity (BMI >60) is increasing at alarming rate! pubmed.ncbi.nlm.nih.gov/4028… Obesity meds have only been tested for mean BMI 34. Will need combination of obesity meds + Metabolic Surgery for this group. @ObesitySociety @WorldObesity @ObesityAction @OMAsocial @ASMBS @IfsoSecretariat @JaimePonceMD @jdscottmd @mattars77 @rvcohen @FRubinoMD @metabolic_knife @Ali_Aminian_MD @MichaelAlbertMD
Philip Schauer, MD retweeted
"Hindsight being 20/20, I would have surgery again." Most respondents said so, but 56% of the unsure or unwilling cited weight recurrence, and only 15% of invitees answered. MBS Digest Vol. 2, Issue 14 also covers GLP-1 agonists after regain and staged SADI-S. Link in reply.

































